Sarepta Therapeutics Inc Q3 2022 Earnings Call Summary - Thomson StreetEvents

Sarepta Therapeutics Inc Q3 2022 Earnings Call Summary

Sarepta Therapeutics Inc Q3 2022 Earnings Call Summary - Thomson StreetEvents
Sarepta Therapeutics Inc Q3 2022 Earnings Call Summary
Published Nov 02, 2022
22 pages (12711 words) — Published Nov 02, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of SRPT.OQ earnings conference call or presentation 2-Nov-22 8:30pm GMT

  
Brief Excerpt:

...A. Highlights: Another strong qtr., serving community with three approved therapies: 1. EXONDYS 51. a. b. VYONDYS 53. c. AMONDYS 45. 2. About $5m anticipated for 3Q22 came in and was booked in 2Q22. Even with that: a. i. Total revenue, approx. $230.3m. ii. Net product revenue, $207.8m; 25% growth YoverY. 3. In 2Q22, raised 2022 guidance: a. Total revenue to $905-920m. b. Net product revenue guidance to $825-840m. c. In light of continuing strong performance, remains comfortable with that guidance. B. SRP-9001: SPR-9001 is gene therapy for Duchenne muscular dystrophy. 1. 2. 2022 has been momentous one for SRP-9001 and for Duchenne community Co. serves. 3. Over course of 1H22, Co. discussed with FDA possibility of submitting Biologics License Application (BLA) for approval of SRP-9001 on accelerated basis. Due to those discussions and written feedback Co. received, it intended to submit BLA for approval of SRP-9001 to treat ambulatory Duchenne patients. a. b. In 3Q22, submitted BLA for SRP-9001....

  
Report Type:

Brief

Source:
Company:
Sarepta Therapeutics Inc
Ticker
SRPT.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Sarepta Therapeutics Inc Q4 2022 Earnings Call Summary – 2023-02-28 – US$ 54.00 – Edited Brief of SRPT.OQ earnings conference call or presentation 28-Feb-23 9:30pm GMT

Sarepta Therapeutics Inc Q4 2022 Earnings Call Transcript – 2023-02-28 – US$ 54.00 – Edited Transcript of SRPT.OQ earnings conference call or presentation 28-Feb-23 9:30pm GMT

Sarepta Therapeutics Inc at JPMorgan Healthcare Conference Transcript – 2023-01-09 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 9-Jan-23 6:30pm GMT

Sarepta Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript – 2022-12-01 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 1-Dec-22 7:15pm GMT

Sarepta Therapeutics Inc Q3 2022 Earnings Call Transcript – 2022-11-02 – US$ 54.00 – Edited Transcript of SRPT.OQ earnings conference call or presentation 2-Nov-22 8:30pm GMT

Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2022-09-12 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 12-Sep-22 4:30pm GMT

Sarepta Therapeutics Inc Q2 2022 Earnings Call Summary – 2022-08-02 – US$ 54.00 – Edited Brief of SRPT.OQ earnings conference call or presentation 2-Aug-22 8:30pm GMT

Sarepta Therapeutics Inc Q2 2022 Earnings Call Transcript – 2022-08-02 – US$ 54.00 – Edited Transcript of SRPT.OQ earnings conference call or presentation 2-Aug-22 8:30pm GMT

Sarepta Therapeutics Inc to Discuss New Clinical Data and Integrated Analysis Call Summary – 2022-07-06 – US$ 54.00 – Edited Brief of SRPT.OQ conference call or presentation 6-Jul-22 12:30pm GMT

Sarepta Therapeutics Inc to Discuss New Clinical Data and Integrated Analysis Call Transcript – 2022-07-06 – US$ 54.00 – Edited Transcript of SRPT.OQ conference call or presentation 6-Jul-22 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Sarepta Therapeutics Inc Q3 2022 Earnings Call Summary" Nov 02, 2022. Alacra Store. May 17, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2022-Sarepta-Therapeutics-Inc-Earnings-Call-B15370332>
  
APA:
Thomson StreetEvents. (2022). Sarepta Therapeutics Inc Q3 2022 Earnings Call Summary Nov 02, 2022. New York, NY: Alacra Store. Retrieved May 17, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2022-Sarepta-Therapeutics-Inc-Earnings-Call-B15370332>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.